Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms.
about
Evolution of subtype C HIV-1 Env in a slowly progressing Zambian infant.18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Côte d'Ivoire: a cohort study.Pneumocystis carinii pneumonia in vertically acquired HIV infection in the British Isles.Contact with thymic epithelial cells as a prerequisite for cytokine-enhanced human immunodeficiency virus type 1 replication in thymocytes.Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants.Breast-feeding and human immunodeficiency virus.Infants born to HIV-1 infected women: lessons from the past decade.Deficient antibody-dependent cellular cytotoxicity against human immunodeficiency virus (HIV)-expressing target cells in perinatal HIV infection.Maturational changes in peripheral lymphocyte subsets pertinent to monitoring human immunodeficiency virus-infected Chinese pediatric patients.Long-term follow-up of children in the HIVNET 012 perinatal HIV prevention trial: five-year growth and survivalImpact of cytokines on replication in the thymus of primary human immunodeficiency virus type 1 isolates from infants.PENTA guidelines for the use of antiretroviral therapy in paediatric HIV infection. Pediatric European Network for Treatment of AIDS.Prognostic value of immunological data, in vitro antibody production, and virus culture in vertical infection with HIV-1Characterization of HIV-1 subtype C envelope glycoproteins from perinatally infected children with different courses of disease.CD4+ lymphocyte-based immunologic outcomes of perinatally HIV-infected children during antiretroviral therapy interruption.Vertically transmitted HIV infection in the British Isles.Type 1 and type 2 cytokine profiles in children exposed to or infected with vertically transmitted human immunodeficiency virus.Pediatric human immunodeficiency virus infection.HIV infection in childrenTiming of antiretroviral therapy initiation and its impact on disease progression in perinatal human immunodeficiency virus-1 infectionLow levels of human immunodeficiency virus replication in the brain tissue of children with severe acquired immunodeficiency syndrome encephalopathy.Longitudinal studies of viral sequence, viral phenotype, and immunologic parameters of human immunodeficiency virus type 1 infection in perinatally infected twins with discordant disease courses.Pediatric infections.Predictors of early mortality in a cohort of human immunodeficiency virus type 1-infected african children.The impact of HIV-1 infection and exposure on natural killer (NK) cell phenotype in Kenyan infants during the first year of life.Disease in children infected with HIV in Abidjan, Côte d'Ivoire.The impact of HIV/AIDS on children in developing countriesDose-dependent long-term effects of Tat in the rat hippocampal formation: a design-based stereological study.Determining an optimal testing strategy for infants at risk for mother-to-child transmission of HIV-1 during the late postnatal period.Home-based care for orphaned children infected with HIV/AIDS in Uganda.The early natural history of vertically transmitted HIV-1 infection in African children from Durban, South Africa.Cellular tropisms and co-receptor usage of HIV-1 isolates from vertically infected children with neurological abnormalities and rapid disease progression.Clinical features and T-cell subsets in HIV-infected children with and without lymphocytic interstitial pneumonitis.Positive regulation of CXCR4 expression and signaling by interleukin-7 in CD4+ mature thymocytes correlates with their capacity to favor human immunodeficiency X4 virus replication.Pneumocystis prophylaxis for all, some, or no HIV-infected infants less than one year of age: A decision analysis approach.Mother-to-infant HIV transmission: timing, risk factors and prevention.Diagnosis and management of opportunistic infections in childhood AIDS.In-utero infection with HIV-1 associated with suppressed lymphoproliferative responses at birth.beta 2-Microglobulin and CD4/CD8 ratio as HIV-1 markers of maternal transmissibility, neonatal infection and disease progression.Early impairment of gut mucosal immunity in HIV-1-infected children.
P2860
Q24815687-D437BF29-E28B-4EBC-A2C8-392FD3A2AEE0Q33336235-532269AD-6CAC-401B-9CB7-F96782A5A078Q33624462-FCF347FC-EC26-4DCE-A1DD-5477F81BCC44Q33785644-D490EEF2-AB36-49AC-8124-14FC73B59E5CQ33843438-D3D993CE-349C-45D5-B793-D685835BF5BCQ33894839-C71986DC-B543-48C3-AC33-03177C34C32AQ33929012-89487FF7-FB27-4ACF-B981-C55565489592Q33997891-94E3FDFB-C634-4F28-BD84-A12EC7F72D3FQ33999439-4920F54F-0E7E-4723-B121-B4E74668B162Q34231039-1681C731-D821-4E62-B505-0566CC9CD9ADQ34342452-6AE47883-FDC3-4C5A-A1AD-D926A37F84B9Q34760550-FB76246B-4F02-40A0-9643-8F8FE61D3598Q34796157-2760768F-7138-439F-B8F4-A88ECCD66FBEQ35127401-1BA6D896-A5EA-4E18-B3AF-AF3F1C63D559Q35166919-39E695E7-1EC0-46BE-986B-FCDE753C0FE1Q35188006-9B1EB7A9-AD36-45C4-BD20-3D365EA6CAD8Q35227609-D3BD0A15-DBE3-41E4-A401-3CF531464D43Q35372072-CC02DC56-F164-4661-81D2-E3092950B062Q35627645-3AA63323-1383-47FC-AC6B-52CFBDE6E49FQ35655827-817CC9D5-711B-47E0-A304-5DD953F38938Q35830957-DA285012-7C75-4C07-B40B-8673F1B422D7Q35861228-DD1372F9-7884-462A-B5B5-C78C23E5BC69Q35893234-57CC5CA4-EC52-41CE-AB77-D70406587ACBQ36049003-F68C1E50-DD4D-4A5F-BFA6-5E3695B117C0Q36496904-75E0E535-9AD9-4FA5-8B49-71397C7360C4Q36597225-43F408E2-88C2-4EC6-8E3C-5DBC466A1AEAQ37293890-26E15B91-85B8-46F8-A2D6-6028C3557079Q37344253-B7894F1D-2810-42F7-A5CF-164A5CAE3D89Q37382748-4001B3BC-640F-474B-A35C-E17725F781C2Q38457057-EEADE45C-5096-4DA1-9F5B-B6EA57084474Q38912539-831722C8-5D75-46A8-A5F4-871B29F87900Q39231465-5CA12E27-C6BF-45B0-8067-2F019235A80FQ39580993-2A2054B0-D77D-4925-B3C1-399AD879E75CQ39748962-2EB5DD47-9B23-418D-829A-9DD743A56E39Q40141479-DBC1379F-3B9B-4503-A5CC-C20DAF8DC60BQ40510235-30FACFE1-1FF0-43F0-8957-BC389309FE05Q40522099-EECD80F5-5974-4CE0-8B01-C10B62D5B13BQ42214247-9F2FCB8F-7698-4B2A-9364-458DE83F40A8Q44319274-D0532FDB-EFE8-49CE-89BF-F20C94BC2522Q45003147-CDC412CF-27EB-492C-8708-04830166C1EA
P2860
Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Longitudinal study of 94 sympt ...... nical and biological symptoms.
@en
Longitudinal study of 94 sympt ...... nical and biological symptoms.
@nl
type
label
Longitudinal study of 94 sympt ...... nical and biological symptoms.
@en
Longitudinal study of 94 sympt ...... nical and biological symptoms.
@nl
prefLabel
Longitudinal study of 94 sympt ...... nical and biological symptoms.
@en
Longitudinal study of 94 sympt ...... nical and biological symptoms.
@nl
P2093
P1476
Longitudinal study of 94 sympt ...... nical and biological symptoms.
@en
P2093
Caniglia M
Fukunaga K
Griscelli C
Le Deist F
P304
P356
10.1001/ARCHPEDI.1990.02150350042021
P577
1990-11-01T00:00:00Z